AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-6.32%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.88B
AUM Growth
+$2.88B
(-25%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-11.96%
Top 10 Holdings %
Top 10 Hldgs %
76.21%
Holding
111
New
12
Increased
16
Reduced
18
Closed
9
Top Buys
| 1 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$69.8M |
| 2 |
Amicus Therapeutics
FOLD
|
$13.3M |
| 3 |
Alibaba
BABA
|
$10.7M |
| 4 |
NIO
NIO
|
$10.5M |
| 5 |
AnaptysBio
ANAB
|
$9.98M |
Top Sells
| 1 |
WW
WW International
WW
|
$432M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$12.9M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.04M |
| 5 |
Immunic
IMUX
|
$6.85M |
Sector Composition
| 1 | Healthcare | 61.03% |
| 2 | Consumer Discretionary | 37.81% |
| 3 | Technology | 0.32% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $1.07B | 27.75% | 14,818,300 -6,000,000 | -29% | -$432M |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $643M | 16.72% | 60,240,864 | – | – |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $103M | 2.69% | 600,000 -75,000 | -11% | -$12.9M |
|
|
RUBY
4
DELISTED
Rubius Therapeutics, Inc
RUBY
| $69.8M | 1.82% | +2,908,791 | New | +$69.8M |
|
5
Scholar Rock
SRRK
$3.14B
| $61.7M | 1.61% | 2,396,040 | – | – |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $57.2M | 1.49% | 1,000,000 | – | – |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $52.5M | 1.37% | 600,000 -50,000 | -8% | -$4.38M |
|
8
Nektar Therapeutics
NKTR
$568M
| $48.8M | 1.27% | 800,000 -100,000 | -11% | -$6.1M |
|
|
9
Amicus Therapeutics
FOLD
$2.34B
| $48.4M | 1.26% | 4,000,000 +1,100,000 | +38% | +$13.3M |
|
10
Atara Biotherapeutics
ATRA
$84.6M
| $41.4M | 1.08% | 1,000,000 | – | – |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $39M | 1.02% | 500,000 -200,000 | -29% | -$15.6M |
|
12
Fate Therapeutics
FATE
$120M
| $35.7M | 0.93% | 2,190,000 +490,000 | +29% | +$7.98M |
|
|
TSRO
13
DELISTED
TESARO, Inc.
TSRO
| $31.2M | 0.81% | 800,000 | – | – |
|
|
14
AnaptysBio
ANAB
$569M
| $29.9M | 0.78% | 300,000 +100,000 | +50% | +$9.98M |
|
|
ARRY
15
DELISTED
Array Biopharma Inc
ARRY
| $28.9M | 0.75% | 1,900,000 -100,000 | -5% | -$1.52M |
|
|
BLUE
16
DELISTED
bluebird bio
BLUE
| $25.6M | 0.66% | 175,000 +5,000 | +3% | +$730K |
|
17
ProQR Therapeutics
PRQR
$237M
| $25.2M | 0.65% | 1,300,000 -200,000 | -13% | -$3.87M |
|
18
Agios Pharmaceuticals
AGIO
$2.19B
| $23.1M | 0.6% | 300,000 -50,000 | -14% | -$3.86M |
|
|
ZGNX
19
DELISTED
Zogenix, Inc.
ZGNX
| $19.8M | 0.52% | 400,000 -100,000 | -20% | -$4.96M |
|
20
Xencor
XNCR
$580M
| $19.5M | 0.51% | 500,000 +100,000 | +25% | +$3.9M |
|
21
InflaRx
IFRX
$108M
| $17.2M | 0.45% | 500,000 | – | – |
|
|
ALBO
22
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $16.5M | 0.43% | 500,000 | – | – |
|
|
AUTL
23
Autolus Therapeutics
AUTL
$399M
| $15.3M | 0.4% | 500,000 -25,000 | -5% | -$767K |
|
24
FibroGen
FGEN
$47.8M
| $15.2M | 0.4% | 250,000 | – | – |
|
|
SAGE
25
DELISTED
Sage Therapeutics
SAGE
| $14.1M | 0.37% | 100,000 | – | – |
|